Tardive

2005 - De echte oorzaken van schizofrenie. Dr. Harold D. Foster. Ortho Communications & Science, Gendringen, prijs € 21,90 ISBN 90-76161-08-9  

2004 - Eaton W, Mortensen PB, Agerbo E, Byrne M, Mors O, Ewald H. Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. BMJ 2004; 328(7437):438-9  

2003 - Ehrenreich H, Degner D, Meller J, Brines M, Behe M, Hasselblatt M, Woldt H, Falkai P, Knerlich F, Jacob S, Von Ahsen N, Maier W, Bruck W, Ruther E, Cerami A, Becker W, Siren AL. Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry 2004; 9:42-54  

2003 - Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 2003; 60(2):133-41  

2002 - Peet M, Horrobin DF. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 2002; 36(1):7-18  

2002 - Emsley R, Myburgh C, Oosthuizen P, van Rensburg SJ. Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 2002; 159(9):1596-1598  

2001 - Mahadik SP, Evans D, Lal H. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25(3):463-493  

1997 - Lohr JB. et al. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. Journal of Clinical Psychiatry 1996;57:167-173  

1997 - Mosnik DM et al. Tardive dyskinesia exacerbated after ingestion of phenylalanine by schizophrenic patients. Neuropsychopharmacology 1996;16;2:136-146.  

1997 - Laugharne JDE et al. Fatty acids and schizophrenia. Lipids 1996;31:S-163-165.